Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal
Investing.com Gold reports: Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal. Full body text was unavailable at ingest time, so this brief is based on headline context.